With the first deadline to implement new medical record regulations less than a year away, bioscience companies should be taking a hard look at whether these complicated US federal mandates will affect them. [ + ]

South Australian genomics research company Bionomics (ASX: BNO) has entered a licensing deal with Johnson & Johnson Research (JJR) to develop angiogenesis drugs. [ + ]

The Australia and New Zealand Food Authority (ANZFA) has invited public comment on its proposal to approve the use of a new version of Monsanto's genetically modified Bt-Cotton. [ + ]

Melbourne scientists have become the first in Australia to culture adult neural stem cells, bringing local medicine a step closer to a potential cure for Parkinson's disease. [ + ]

Business management students were told yesterday that they may have to work overseas before they sought employment in Australia's biotechnology industry. [ + ]

Public concern over deep vein thrombosis has helped boost revenues of listed biotech Agenix to a record $29 million in the nine months to March 31. [ + ]

A device for the early detection of skin cancer has been launched by Sydney-based medical device company, Polartechnics. [ + ]

A consortium of eight research groups is pitching for Victorian Government support in a bid to become Australia's first fee-for-service pharmaceutical pipeline group. [ + ]

Victoria's government has unveiled a cash injection of $68.7 million for biotechnology and commercialisation, including a doubling in funding for medical research infrastructure in a bid to lure top scientists back to the state. [ + ]

With the legal closing on Friday May 3 of its Compaq acquisition, and a turbulent nine months behind it, Hewlett-Packard is at last poised to commence merged operations. [ + ]

Melbourne-based researchers are developing a transgenic rye grass that will reduce the risk of hay fever in allergy sufferers. [ + ]

Monsanto and Nufarm have given Australia's consumer watchdog court-enforceable undertakings that they will not try to stop agricultural glyphosate herbicides being imported from China. [ + ]

CEOs of Australia's leading technology companies believe that the biotechnology and internet security sectors have the greatest potential for growth in the next 12 months, according to a Deloitte industry survey. [ + ]

Peptech will reap further profits from its Remicade anti-TNF antibody in Britain. [ + ]

Former Prime Minister Bob Hawke has resigned as a director of Autogen's board, citing heavy business and personal commitments. [ + ]